Fixing FDA's Sclerotic Drug-Approval Process
The Promising Pathway Act is designed to incentivize companies to offer patients the freedom to use not-yet-approved drugs. The legislation could be a game-changer.
Read Full Article »
Comment
Show comments
Hide Comments
